Abstract
Objective Deamidation of the NGR (Asn-Gly-Arg) motif to the isoDGR (isoAsp-Gly-Arg) motif in fibronectin (IsoDGR-fibronectin) enhances in vitro monocyte and endothelial cell activation. Blocking isoDGR reduces macrophage influx in murine tissues. Although macrophage influx is an important feature of human plaque destabilization, the role for plasma and plaque isoDGR-fibronectin in macrophage influx in the atherosclerotic plaque and thereby increasing plaque vulnerability has not been investigated in large human cohorts.
Design IsoDGR-fibronectin levels in plasma and plaques were measured in carotid endarterectomy (CEA) patients from the Athero Express biobank cohort and associated with macrophage and other vulnerable plaque characteristics in the carotid plaque of the same patient.
Methods Levels of isoDGR-fibronectin were measured using an ELISA. Carotid plaque characteristics were visualized with immunohistochemistry staining and scored semi-quantitatively. Baseline characteristics were analysed with Pearson’s Chi-squared test and Mann-Whitney U-test when applicable. Univariate and multivariate logistics regression analyses were used to identify associations with adverse plaque characteristics.
Results Plasma isoDGR-fibronectin was measured in 730 CEA patients. Patients with moderate/heavy plaque macrophage staining had higher levels of isoDGR-fibronectin than patients with no/minor macrophage staining (multivariate OR 1.40 (95%CI 1.04 – 1.90, p=0.028)). Of the 730 CEA patients, 348 had plaque samples available for isoDGR-fibronectin measurements. In the multivariate analysis, higher plaque levels of isoDGR-fibronectin were associated with moderate/high plaque macrophage staining (OR 1.22 (95%CI 1.00 – 1.56, p=0.049)), >40% fat in plaque (OR 1.1.44 (95% CI 1.14 – 1.86, p=0.004)) and intraplaque haemorrhage (OR 1.38 (95% 1.12 – 1.72, p=0.003)).
Conclusion In this large human cohort study high plasma and plaque levels of isoDGR-fibronectin were associated with more plaque macrophages and other adverse plaque characteristics. This suggests the involvement of isoDGR-fibronectin in human plaque destabilization that may lead to new potential treatment modalities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was retrieved for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
METC of University Medical Center Utrecht and the St Antonius Hospital Nieuwegein Patients who undergo a carotid endarterectomy in the University Medical Center Utrecht or the St Antonius Hospital Nieuwegein were included to the Athero-Express ongoing, longitudinal biobank study with collecting carotid atherosclerotic plaques. Written informed consent was provided for all included patients and medical ethics committees of both participating centers approved the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos